Covestor LTD Organon & Co. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Organon & Co. stock. As of the latest transaction made, Covestor LTD holds 9,196 shares of OGN stock, worth $135,457. This represents 0.11% of its overall portfolio holdings.

Number of Shares

9,196

Previous 13,291 30.81%

Holding current value

$135,457

Previous $275,000 36.0%

% of portfolio

0.11%

Previous 0.18%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$18.65 - $23.03 $76,371 - $94,307	-4,095 Reduced 30.81%	9,196 $176,000
Q2 2024 Aug 09, 2024	SELL	$17.45 - $21.96 $3,559 - $4,479	-204 Reduced 1.51%	13,291 $275,000
Q1 2024 May 10, 2024	BUY	$13.78 - $18.8 $15,185 - $20,717	1,102 Added 8.89%	13,495 $254,000
Q4 2023 Feb 09, 2024	BUY	$10.95 - $17.32 $20,191 - $31,938	1,844 Added 17.48%	12,393 $179,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $35,137 - $50,344	2,118 Added 25.12%	10,549 $183,000
Q2 2023 Aug 11, 2023	BUY	$19.27 - $24.63 $28,750 - $36,747	1,492 Added 21.5%	8,431 $175,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $23,155 - $34,678	-1,081 Reduced 13.48%	6,939 $163,000
Q4 2022 Feb 13, 2023	BUY	$23.31 - $28.61 $78,950 - $96,902	3,387 Added 73.11%	8,020 $224,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $100,175 - $146,624	4,281 Added 1216.19%	4,633 $108,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $158 - $194	-5 Reduced 1.4%	352 $12,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $4,689 - $6,061	154 Added 75.86%	357 $12,000
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $5,820 - $7,537	203 New	203 $6,000

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account